Best-Selling Drugs For full list, visit www.njbiz.com/lists
Ranked by fourth quarter 2011 retail sales By Danielle Mack
1 | 1 | Lipitor
| Pfizer Inc.
| Cholesterol-lowering
| -10.4%
| $64,084,958
| $57,389,069
|
2 | 2 | Nexium
| AstraZeneca
| Heartburn and acid reflux
| -9.0%
| $54,904,679
| $49,970,296
|
3 | 3 | Plavix
| Bristol-Myers Squibb Co.
| Heart attack
| -6.6%
| $44,830,607
| $41,850,364
|
4 | 5 | Crestor
| AstraZeneca
| Cholesterol and atherosclerosis
| 4.7%
| $33,057,048
| $34,607,285
|
5 | 4 | OxyContin
| Purdue Pharma
| Pain relief
| -7.8%
| $34,557,605
| $31,874,590
|
6 | 7 | Singulair
| Merck & Co. Inc.
| Asthma and seasonal allergies
| 2.9%
| $28,430,427
| $29,241,177
|
7 | 6 | Advair Diskus
| GlaxoSmithKline PLC
| Asthma
| -7.5%
| $31,609,669
| $29,239,507
|
8 | 8 | Abilify
| Otsuka
Bristol-Myers Squib Co.
| Bipolar disorder and schizophrenia
| 10.5%
| $24,007,616
| $26,535,384
|
9 | 9 | Lexapro
| Forest Pharma Co.
| Depression and generalized anxiety disorder
| 1.5%
| $22,180,314
| $22,523,970
|
10 | 16 | Cymbalta
| Eli Lilly & Co.
| Depression
| 13.3%
| $16,570,464
| $18,767,234
|
11 | 13 | Seroquel
| AstraZeneca
| Bipolar disorder
| 2.6%
| $17,796,828
| $18,256,145
|
12 | 14 | Januvia
| Merck & Co. Inc.
| Type 2 diabetes
| 3.8%
| $17,002,972
| $17,652,108
|
13 | 12 | Diovan HCT
| Novartis Pharmaceuticals Corp.
| Blood pressure and a diuretic
| -7.4%
| $18,150,710
| $16,809,909
|
14 | 15 | Diovan
| Novartis Pharmaceuticals Corp.
| Blood pressure
| -2.6%
| $16,937,572
| $16,490,313
|
15 | 19 | Spiriva
| Boehringer Ingelheim Pharma
| Breathing problems associated with COPD
| 14.1%
| $13,736,264
| $15,671,184
|
16 | 17 | Lovaza
| GlaxoSmithKline Consumer Healthcare
| Reduce very high triglycerides
| -5.5%
| $15,225,493
| $14,380,870
|
17 | NR | Incivek
| Vertex Pharmaceuticals
| Hepatitis C
| NA
| NA
| $14,271,080
|
18 | 10 | Actos
| Takeda
| Type 2 diabetes
| -34.5%
| $21,784,731
| $14,262,628
|
19 | 22 | Suboxone
| Reckitt Benckiser LLC
United Therapeutics
| Opiate addiction
| 10.3%
| $12,018,802
| $13,260,003
|
20 | 20 | Metoprolol Succinate
| Watson Pharma
Wockhardt USA
| Hypertension
| -11.3%
| $14,823,968
| $13,155,037
|
21 | 25 | Alprazolam
| Pfizer Inc.
Mylan
| Anxiety
| 11.5%
| $11,677,601
| $13,020,504
|
22 | NR | Oxycodone
| Actavis Group
Covidien
| Pain pills
| 24.5%
| $9,492,556
| $11,814,343
|
23 | 32 | Lantus SoloSTAR
| Sanofi US
| Insulin
| 24.5%
| $8,968,572
| $11,164,637
|
24 | NR | Atripla
| Bristol-Myers Squibb Co.
| HIV
| -3.7%
| $11,401,751
| $10,981,015
|
25 | 38 | Provigil
| Cephalon Inc.
| Improve wakefulness in adults who experience excessive sleepiness
| 26.2%
| $8,609,397
| $10,866,649
|
26 | 21 | Lidoderm
| Endo Pharmaceuticals Inc.
| Post-herpetic neuralgia pain reliever
| -13.6%
| $12,476,248
| $10,773,855
|
27 | NR | Atorvastatin Calcium
| Watson Pharma
Daiichi-Sankyo
| generic Lipitor
| NA
| NA
| $10,072,246
|
28 | 23 | Celebrex
| Pfizer Inc.
| Arthritis
| -8.2%
| $10,764,619
| $9,880,331
|
29 | 26 | Lyrica
| Pfizer Inc.
| Fibromyalgia and nerve pain
| -1.5%
| $10,010,814
| $9,864,750
|
30 | 33 | Azithromycin
| Pfizer Inc.
Novartis
| Antibiotic
| 3.7%
| $9,508,345
| $9,864,208
|
31 | 28 | Truvada
| Gilead Sciences
| HIV treatment
| 1.5%
| $9,552,715
| $9,692,833
|
32 | 31 | Solodyn
| Medicis Pharmaceutical Corp.
| Acne
| 1.1%
| $9,297,304
| $9,402,510
|
33 | 39 | NovoLog
| Novo Nordisk Inc.
| Insulin
| 6.7%
| $8,484,802
| $9,051,272
|
34 | 36 | Nasonex
| Merck & Co. Inc.
| Seasonal allergies
| -0.5%
| $8,798,409
| $8,754,143
|
35 | 27 | Tricor
| Abbott Laboratories Pharmaceutical Products
| High cholesterol
| -11.8%
| $9,890,768
| $8,718,836
|
36 | NR | Enoxaparin Sodium
| Novartis Pharmaceuticals Corp.
Winthrop US
| Generic Lovenox and Clexane
| 37.5%
| $6,064,974
| $8,341,909
|
37 | 30 | Zetia
| Merck & Co. Inc.
| Cholesterol
| -11.0%
| $9,366,471
| $8,337,065
|
38 | 45 | Janumet
| Merck & Co. Inc.
| Type 2 diabetes
| 11.0%
| $7,345,516
| $8,152,562
|
39 | 40 | Viagra
| Pfizer Inc.
| Erectile dysfunction
| -3.9%
| $8,373,162
| $8,050,367
|
40 | NR | Amphetmn Salt Cmb SR
| Teva Pharmaceuticals
IMPAX Labs
| Generic
| 30.3%
| $6,147,053
| $8,007,313
|
41 | 37 | Aciphex
| Eisai Inc.
| Acid reflux
| -9.0%
| $8,732,731
| $7,947,350
|
42 | 47 | Budesonide
| Teva Pharmaceuticals
Par Pharm
| Asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for Crohn's disease (inflammatory bowel disease).
| 14.9%
| $6,872,739
| $7,895,170
|
43 | NR | Methylphenidate ER
| Watson Pharma
Covidien
| Attention deficit hyperactivity disorder
| NA
| NA
| $7,838,569
|
44 | NR | Fexofenadine
| Dr. Reddy's Laboratories Inc.
Teva Pharmaceuticals
| Antihistamine
| 46.7%
| $5,097,200
| $7,478,502
|
45 | NR | Olanzapine
| Teva Pharmaceuticals
Prasco Laboratories
| Antipsychotic used to treat schizophrenia and manic episodes of bipolar disorder
| NA
| NA
| $7,464,166
|
46 | NR | Lunesta
| Dainippon Sumitomo Pharm
| Sleep aid
| -13.2%
| $8,345,038
| $7,247,145
|
47 | 42 | Loestrin 24 Fe
| Warner Chilcott Inc.
| Oral contraceptive
| -11.1%
| $8,110,645
| $7,207,969
|
48 | NR | Vyvanse
| Shire Pharm Group
| Attention Deficit /
Hyperactivity Disorder
| 32.5%
| $5,253,173
| $6,960,925
|
49 | 49 | ProAir HFA
| Teva Pharmaceuticals
| Asthma inhailer
| 10.0%
| $6,238,596
| $6,862,647
|
50 | NR | Cialis
| Eli Lilly & Co.
| Erectile Dysfunction Treatment
| 7.3%
| $6,050,682
| $6,492,571
|
|
